ARQT logo

Arcutis Biotherapeutics (ARQT)

Profile

Full Name

Arcutis Biotherapeutics, Inc.

Ticker Symbol

ARQT

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

January 31, 2020

Indexes

Not included

Website

http://www.arcutis.com

Employees

342

Key Details

Price

$13.19(+1.93%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$196.54M(+229.74% YoY)

Annual EPS

-$1.16(+69.31% YoY)

PE ratio

-

Next earnings date

May 14, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$13.19
ARQT price is $13.19

30-Day Relative Volume

0.86
ARQT 30-day relative volume is 0.86

Price Performance

Price Most recent change

+1.93%
ARQT price was up +1.93% on Apr 15, 2025

Price YTD change

-5.31%
ARQT price is down -5.31% since January 1st

Price 1-year change

+30.72%
ARQT price is up +30.72% year-on-year

Price 3-year change

-37.28%
ARQT price is down -37.28% over the past 3 years

Price Range

Price All-time high

$40.88
ARQT price is currently -67.73% below its historical high of $40.88

Price 3-year low

$1.76
ARQT price is currently +649.43% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$1.56B
ARQT market capitalization is $1.56 billion

Market cap 3-year change

+44.72%
ARQT market capitalization is up +44.72% over the past 3 years

Market cap All-time high

$2.05B
ARQT market capitalization is currently -23.71% below its historical high of $2.05 billion

Market cap sector rank

80.92%
ARQT market capitalization is higher than 80.92% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+2.71%
ARQT shares outstanding is up +2.71% year-on-year

Shares Outstanding 3-Year Change

+130.73%
ARQT shares outstanding is up +130.73% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.22
ARQT beta is 1.22

200-day SMA

$11.72
ARQT price is currently +12.54% above its 200-day simple moving average

50-day SMA

$14.21
ARQT price is currently -7.15% below its 50-day simple moving average

RSI

42.10
ARQT 14-day relative strength index is 42.10

Volume

0.86
ARQT 30-day relative volume is 0.86

ATR

$1.35
ARQT average true range is $1.35

10-day Historical Volatility

112.76%
ARQT 10-day historical volatility is 112.76%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$196.54M
ARQT annual revenue is $196.54 million

Revenue Analysts estimate

$309.41M
ARQT annual revenue is currently -36.48% lower than the consensus analysts' forecast

Revenue 1-year change

+229.74%
ARQT annual revenue is up +229.74% year-on-year

Revenue Sector rank

63.46%
ARQT annual revenue is higher than 63.46% of companies in Healthcare sector

EPS

EPS

-$1.16
ARQT annual earnings per share is -$1.16

EPS Analysts estimate

-$0.56
ARQT annual earnings per share is currently +106.52% higher than the consensus analysts' forecast

EPS 1-year change

+69.31%
ARQT annual earnings per share is up +69.31% year-on-year

EPS Sector rank

52.78%
ARQT annual earnings per share is higher than 52.78% of companies in Healthcare sector

Profit

Gross profit

$177.41M
ARQT annual gross profit is $177.41 million

Gross margin

90.27%
ARQT annual gross profit margin is 90.27%

Operating profit

-$128.40M
ARQT annual operating income is -$128.40 million

Operating margin

-65.33%
ARQT annual operating profit margin is -65.33%

Net income

-$140.04M
ARQT annual net profit is -$140.04 million

Net margin

-71.25%
ARQT annual net profit margin is -71.25%

Expenses

Total expenses

$324.94M
ARQT annual total expenses is $324.94 million

Operating expenses

$305.81M
ARQT annual total operating expenses is $305.81 million

Cost of goods sold

$19.13M
ARQT annual cost of goods sold is $19.13 million

Selling, general & administrative expenses

$229.39M
ARQT annual SGA is $229.39 million

Depreciation and amortization

$2.60M
ARQT annual depreciation & amortization is $2.60 million

Interest expense

$27.17M
ARQT annual interest expense is $27.17 million

Income tax

$647.00K
ARQT annual income tax is $647.00 thousand

EBIT & EBITDA

EBIT

-$112.22M
ARQT annual earnings before interest & taxes is -$112.22 million

EBITDA

-$109.63M
ARQT annual EBITDA is -$109.63 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$348.89M
ARQT annual total assets is $348.89 million

Non current assets

$13.07M
ARQT annual long term assets is $13.07 million

Current assets

$335.82M
ARQT annual total current assets is $335.82 million

Cash and cash equivalents

$71.33M
ARQT annual cash & cash equivalents is $71.33 million

Accounts receivable

$73.07M
ARQT annual accounts receivable is $73.07 million

Inventory

$14.53M
ARQT annual inventory is $14.53 million

Liabilities

Total liabilities

$191.35M
ARQT annual total liabilities is $191.35 million

Long term liabilities

$110.33M
ARQT annual total long term liabilities is $110.33 million

Current liabilities

$81.01M
ARQT annual total current liabilities is $81.01 million

Accounts payable

$14.22M
ARQT annual accounts payable is $14.22 million

Debt

Total debt

$110.58M
ARQT annual total debt is $110.58 million

Total debt 1-year change

-46.3%
ARQT annual total debt is down -46.3% year-on-year

Long term debt

$109.77M
ARQT annual long term debt is $109.77 million

Short term debt

$820.00K
ARQT annual short term debt is $820.00 thousand

Equity & Capital

Shareholders equity

$157.54M
ARQT annual stockholders equity is $157.54 million

Book value

$157.54M
ARQT annual book value is $157.54 million

Retained earnings

-$1.12B
ARQT annual retained earnings is -$1.12 billion

Working capital

$254.81M
ARQT annual working capital is $254.81 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$112.16M
ARQT annual cash flow from operations is -$112.16 million

Cash from operations 1-year change

+54.6%
ARQT annual cash flow from operations is up +54.6% year-on-year

Cash from investing

$28.82M
ARQT annual cash flow from investing activities is $28.82 million

Cash from investing 1-year change

-84.01%
ARQT annual cash flow from investing activities is down -84.01% year-on-year

Cash from financing

$66.20M
ARQT annual cash flow from financing activities is $66.20 million

Cash from financing 1-year change

-34.66%
ARQT annual cash flow from financing activities is down -34.66% year-on-year

CAPEX

CAPEX

$5.14M
ARQT annual capital expenditures is $5.14 million

CAPEX 1-year change

+1101.64%
ARQT annual capital expenditures is up +1101.64% year-on-year

Free Cash Flow

Free cash flow

-$117.30M
ARQT annual free cash flow is -$117.30 million

Free cash flow 1-year change

+52.6%
ARQT annual free cash flow is up +52.6% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

90.27%
ARQT annual gross profit margin is 90.27%

Operating margin

-65.33%
ARQT annual operating profit margin is -65.33%

Net margin

-71.25%
ARQT annual net profit margin is -71.25%

ROA & ROE

ROA

-40.58%
ARQT annual return on assets is -40.58%

ROE

-113.76%
ARQT annual return on equity is -113.76%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
ARQT price to earnings ratio value is unknown

PE ratio Sector rank

-
ARQT price to earnings ratio is unknown

PB Ratio

PB ratio

9.93
ARQT price to book ratio is 9.93

PB ratio Sector rank

92.1%
ARQT price to book ratio is higher than 92.1% of companies in Healthcare sector

PS Ratio

PS ratio

7.96
ARQT price to sales ratio is 7.96

PS ratio Sector rank

75%
ARQT price to sales ratio is higher than 75% of companies in Healthcare sector

Enterprise value

Enterprise value

$1.60B
ARQT enterprise value is $1.60 billion

Enterprise value Sector rank

79.82%
ARQT enterprise value is higher than 79.82% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-14.63
ARQT EV/EBITDA is -14.63

EV/EBITDA Sector rank

8.36%
ARQT EV/EBITDA is higher than 8.36% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

4.15
ARQT annual current ratio is 4.15

Quick ratio

3.97
ARQT annual quick ratio is 3.97

Leverage

Debt to equity

0.68
ARQT annual debt to equity ratio is 0.68

Interest coverage ratio

-4.13
ARQT annual interest coverage ratio is -4.13

Risk & Stability

Piotroski F-Score

4
ARQT piotroski f-score is 4

Altman Z-Score

0.78
ARQT altman z-score is 0.78

Analyst ratings

Recent major analysts updates

Apr 9, 25 Needham
Buy
Apr 3, 25 Needham
Buy
Apr 3, 25 HC Wainwright & Co.
Buy
Apr 3, 25 Guggenheim
Buy
Mar 11, 25 Jefferies
Buy
Feb 27, 25 Goldman Sachs
Neutral
Feb 26, 25 Needham
Buy
Feb 26, 25 Mizuho
Outperform
Feb 26, 25 HC Wainwright & Co.
Buy
Feb 24, 25 Guggenheim
Buy

Institutional Ownership

Similar stocks

UFPT logo
UFP Technologies (UFPT)
GLPG logo
Galapagos NV (GLPG)
ATRC logo
AtriCure (ATRC)
BCRX logo
BioCryst Pharmaceuticals (BCRX)
KNSA logo
Kiniksa Pharmaceuticals (KNSA)
CNTA logo
Centessa Pharmaceuticals (CNTA)
AGIO logo
Agios Pharmaceuticals (AGIO)
CGON logo
CG Oncology (CGON)
ASTH logo
Astrana Health (ASTH)
  • What is the ticker symbol for Arcutis Biotherapeutics?
  • Does Arcutis Biotherapeutics pay dividends?
  • What sector is Arcutis Biotherapeutics in?
  • What industry is Arcutis Biotherapeutics in?
  • What country is Arcutis Biotherapeutics based in?
  • When did Arcutis Biotherapeutics go public?
  • Is Arcutis Biotherapeutics in the S&P 500?
  • Is Arcutis Biotherapeutics in the NASDAQ 100?
  • Is Arcutis Biotherapeutics in the Dow Jones?
  • When was Arcutis Biotherapeutics's last earnings report?
  • When does Arcutis Biotherapeutics report earnings?
  • Should I buy Arcutis Biotherapeutics stock now?

What is the ticker symbol for Arcutis Biotherapeutics?

The ticker symbol for Arcutis Biotherapeutics is NASDAQ:ARQT

Does Arcutis Biotherapeutics pay dividends?

No, Arcutis Biotherapeutics does not pay dividends

What sector is Arcutis Biotherapeutics in?

Arcutis Biotherapeutics is in the Healthcare sector

What industry is Arcutis Biotherapeutics in?

Arcutis Biotherapeutics is in the Biotechnology industry

What country is Arcutis Biotherapeutics based in?

Arcutis Biotherapeutics is headquartered in United States

When did Arcutis Biotherapeutics go public?

Arcutis Biotherapeutics's initial public offering (IPO) was on January 31, 2020

Is Arcutis Biotherapeutics in the S&P 500?

No, Arcutis Biotherapeutics is not included in the S&P 500 index

Is Arcutis Biotherapeutics in the NASDAQ 100?

No, Arcutis Biotherapeutics is not included in the NASDAQ 100 index

Is Arcutis Biotherapeutics in the Dow Jones?

No, Arcutis Biotherapeutics is not included in the Dow Jones index

When was Arcutis Biotherapeutics's last earnings report?

Arcutis Biotherapeutics's most recent earnings report was on Feb 25, 2025

When does Arcutis Biotherapeutics report earnings?

The next expected earnings date for Arcutis Biotherapeutics is May 14, 2025

Should I buy Arcutis Biotherapeutics stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page